Rakuten Medical Sues Illumina to Clear ‘Illuminox’ Trademark (2)

Rakuten Medical Inc. says in a suit in a San Francisco federal court that its Illuminox cancer-treatment platform is unlikely to cause confusion with Illumina Inc.‘s trademarks.

The Wednesday complaint in the U.S. District Court for the Northern District of California also says Illumina “essentially seeks to monopolize all ILLUM-formative marks in the medical industry.”

Rakuten Medical’s Illuminox uses light-excitable dye to target and kill tumor cells with antibodies without affecting the tissue around them. Rakuten Medical says it adopted the Illuminox trademark in 2019.

But genetic analysis company Illumina has opposed Rakuten Medical’s attempts to register Illuminox trademarks, ...